95853-51-3

Usage

Uses

Used in Pharmaceutical Industry:
2-GIANIDINOTHIAZOLE-4-METHYLTHIOL is used as a key intermediate in the synthesis of 2-(pyridylmethylthio)benzimidazoles and their analogs, which are compounds with potential applications in the control of Helicobacter bacteria. These bacteria are known to cause various gastrointestinal disorders, including peptic ulcers and gastritis, and are also associated with an increased risk of gastric cancer.
The development of 2-GIANIDINOTHIAZOLE-4-METHYLTHIOL-based compounds aims to provide effective treatments for Helicobacter infections, offering an alternative to traditional antibiotic therapies. These compounds may exhibit enhanced selectivity, reduced side effects, and lower potential for resistance development compared to conventional antibiotics.
Furthermore, the unique chemical structure of 2-GIANIDINOTHIAZOLE-4-METHYLTHIOL allows for the possibility of further modifications and optimization, enabling the design of more potent and selective analogs with improved pharmacological properties. This could lead to the discovery of novel therapeutic agents for the treatment of Helicobacter infections and other related conditions.